Mutations in XPR1, a gene encoding an inorganic phosphate exporter, have recently been identified in patients with primary familial brain calcification (PFBC). Using Sanger sequencing, we screened XPR1 in 18 unrelated patients with PFBC and no SLC20A2, PDGFB, or PDGFRB mutation. XPR1 variants were tested in an in vitro physiological complementation assay and patient blood cells were assessed ex vivo for phosphate export. We identified a novel c.260T > C, p.(Leu87Pro) XPR1 variant in a 41-year-old man complaining of micrographia and dysarthria and demonstrating mild parkinsonism, cerebellar ataxia and executive dysfunction. Brain (123)I-Ioflupane scintigraphy showed marked dopaminergic neuron loss. Peripheral blood cells from the patient exhibited decreased phosphate export. XPR1 in which we introduced the mutation was not detectable at the cell surface and did not lead to phosphate export. These results confirm that loss of XPR1-mediated phosphate export function causes PFBC, occurring in less than 8 % of cases negative for the other genes, and may be responsible for parkinsonism.
XPR1 mutations are a rare cause of primary familial brain calcification
Anheim§, M.; Lopez-Sanchez§, U.; Giovannini, D.; Richard, A. C.; Touhami, J.; N'Guyen, L.; Rudolf, G.; Thibault-Stoll, A.; Frebourg, T.; Hannequin, D.; Campion, D.; Battini*, J. L.; Sitbon*, M.; Nicolas*, G.
2016-08 / vol 263 / pages 1559-64
1432-1459 (Electronic) 0340-5354 (Linking)
IGMM team(s) involved in this publication
Retroviruses, Envelopes and Metabolic Markers
Fahr disease; Idiopathic basal ganglia calcification; Phosphate export; Primary familial brain calcification; Xpr1